BCM
RVPHW

Bluefin Capital Management’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Bluefin Capital Management’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-75,307
Closed -$33.6K – 419
2020
Q2 		$35K Sell
75,307
-10,071
-12% -$2.36K ﹤0.01% 317
2020
Q1 		$8K Hold
85,378
– – ﹤0.01% 386
2019
Q4 		$8K Hold
85,378
– – ﹤0.01% 543
2019
Q3 		$15K Hold
85,378
– – ﹤0.01% 453
2019
Q2 		$17K Hold
85,378
– – ﹤0.01% 291
2019
Q1 		$14K Hold
85,378
– – ﹤0.01% 354
2018
Q4 		$28K Buy
+85,378
New +$27.4K ﹤0.01% 350

Other funds holding RVPHW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Bluefin Capital Management's RVPHW Position: Q3 2020 in Review

Bluefin Capital Management sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2020, closing a stake of 75,307 shares — an estimated $33.6K sold.

Bluefin Capital Management first reported a position in RVPHW in Q4 2018 and held it in 7 quarters. The position peaked at $35K in Q2 2020. 14 funds tracked by Wall St. Rank hold RVPHW as of Q3 2020.

  • Bluefin Capital Management reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 75,307 Reviva Pharmaceuticals Warrants shares in Q3 2020, an estimated $33.6K.
  • Bluefin Capital Management first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 7 quarters.
  • Bluefin Capital Management's Reviva Pharmaceuticals Warrants position peaked at $35K in Q2 2020.
  • 14 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2020.

Based on Bluefin Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.